骨骼生长刺激器市场规模、份额、成长分析（按材料类型、应用、最终用户和地区）- 2025 年至 2032 年产业预测

Bone Growth Stimulators Market Size, Share, and Growth Analysis, By Material Type, By Application, By End User, By Region - Industry Forecast 2025-2032

出版日期: 2025年04月01日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计 2023 年全球骨骼生长刺激器市值将达到 28 亿美元，并从 2024 年的 29.6 亿美元增长到 2032 年的 45.7 亿美元，预测期内（2025-2032 年）的复合年增长率为 5.6%。

由于全球骨折和运动伤害发生率的不断增加，骨骼生长刺激市场正在经历显着增长。美国每年每百万人中约有 54 人发生脊髓损伤，全球每年约有 25 万至 50 万例脊髓损伤，这推动了对骨骼刺激器的需求。当骨折无法充分癒合时，这些装置至关重要。该技术使整形外科手术变得先进，在脊椎融合手术、牙科和骨折修復方面具有很高的应用价值。此外，正在进行的骨生成激素临床研究凸显了其巨大的市场潜力。随着骨关节炎和退化性骨骼病患病率的不断上升，市场也有望受益于富含血小板血浆的日益普及和治疗效果的改善。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业市场定位（2024年）
主要市场参与者所采取的策略
近期市场趋势
公司市场占有率分析（2024年）
主要企业简介
- 公司详情
- 产品系列分析
- 公司分部份额分析
- 收益与前一年同期比较对比（2022-2024 年）
  主要企业简介
  - Orthofix Holdings, Inc.（美国）
  - 美敦力公司（爱尔兰）
  - Zimmer Biomet Holdings, Inc.（美国）
  - 史赛克公司（美国）
  - 泰尔茂株式会社（日本）
  - Bioventus LLC（美国）
  - Igea SpA（义大利）
  - Ossatec AS（挪威）
  - BIoTronik SE & Co. KG（德国）
  - DJO Global, Inc.（美国）
  - EMS Physio Ltd.（英国）
  - Orthocell Ltd.（澳洲）
  - Altis Biologics（南非）
  - ISTO Biologics（美国）
  - Regenlab SA（瑞士）
  - Exactech公司（美国）
  - 胶原蛋白基质公司（美国）
  - ATEC公司（美国）

结论和建议

简介目录

Product Code: SQMIG35A2314

Global Bone Growth Stimulators Market size was valued at USD 2.8 billion in 2023 and is poised to grow from USD 2.96 billion in 2024 to USD 4.57 billion by 2032, growing at a CAGR of 5.6% during the forecast period (2025-2032).

The bone growth stimulation market is witnessing significant growth, driven by an increasing incidence of bone fractures and sports injuries globally. With around 54 cases of spinal cord injury annually per million people in the U.S., and an estimated 250,000 to 500,000 spinal cord injuries worldwide, demand for bone stimulators is rising. These devices are crucial in cases where fractures do not heal adequately. The technology has advanced Orthopaedic surgeries and has high application in spinal fusion, dentistry, and fracture repair. Furthermore, the ongoing clinical research into bone morphogenetic proteins highlights strong market potential. Coupled with the rising prevalence of osteoarthritis and degenerative bone diseases, the market is also expected to benefit from the growing popularity of platelet-rich plasma and improved healing outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bone Growth Stimulators market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bone Growth Stimulators Market Segments Analysis

Global Bone Growth Stimulators Market is segmented by Material Type, Application, End User and region. Based on Material Type, the market is segmented into Bone Growth Stimulation Devices, Bone Morphogenetic Proteins and Platelet-Rich Plasma. Based on Application, the market is segmented into Spinal Fusion Surgeries, Delayed Union & Nonunion Bone Fractures, Oral & Maxillofacial Surgeries and Other Applications. Based on End User, the market is segmented into Hospitals and Ambulatory Surgical Centers, Home Care Settings and Academic and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Bone Growth Stimulators Market

The Global Bone Growth Stimulators market is significantly driven by the increasing occurrence of orthopedic disorders, including fractures, delayed unions, non-unions, and fractures resulting from osteoporosis. As the population ages, the prevalence of these orthopedic issues is on the rise, leading to a heightened demand for effective treatment options such as bone growth stimulators. This trend reflects a broader understanding of the necessity for advanced therapeutic interventions that cater to the needs of individuals suffering from these conditions, thereby propelling market growth and innovation in the development of bone growth stimulation technologies.

Restraints in the Global Bone Growth Stimulators Market

The Global Bone Growth Stimulators market faces certain limitations primarily due to potential side effects and risks linked to their usage. Although these stimulators are largely deemed safe, issues such as skin irritation, allergic reactions, and discomfort during treatments can arise. These concerns may lead to hesitation among patients and healthcare professionals alike, potentially discouraging them from opting for bone growth stimulators. As a result, the perceived risk of adverse effects could hinder market growth and adoption rates, impacting the overall acceptance of these devices within the medical community and among patients seeking effective treatment options.

Market Trends of the Global Bone Growth Stimulators Market

The Global Bone Growth Stimulators market is witnessing a significant shift towards non-invasive treatment options, driven by an increasing demand for patient-friendly solutions. As healthcare providers and patients alike prioritize comfort and minimally invasive procedures, bone growth stimulators have gained traction as effective alternatives to traditional surgical interventions. This trend is particularly pronounced in orthopedic applications, such as spinal fusion and fracture repairs, where the emphasis on faster recovery and reduced complications aligns with the broader healthcare movement towards safer and more efficient therapeutic modalities. Such developments are expected to propel market growth and innovation in the coming years.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Bone Growth Stimulators Market Size by Material Type & CAGR (2025-2032)

Market Overview
Bone Growth Stimulation Devices
- External Bone Growth Stimulators
- Ultrasonic Bone Growth Stimulators
- Implanted Bone Growth Stimulators
Bone Morphogenetic Proteins
Platelet-Rich Plasma

Global Bone Growth Stimulators Market Size by Application & CAGR (2025-2032)

Market Overview
Spinal Fusion Surgeries
Delayed Union & Nonunion Bone Fractures
Oral & Maxillofacial Surgeries
Other Applications

Global Bone Growth Stimulators Market Size by End User & CAGR (2025-2032)

Market Overview
Hospitals and Ambulatory Surgical Centers
Home Care Settings
Academic and Research Institutes

Global Bone Growth Stimulators Market Size & CAGR (2025-2032)

North America (Material Type, Application, End User)
- US
- Canada
Europe (Material Type, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Material Type, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Material Type, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Material Type, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Orthofix Holdings, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zimmer Biomet Holdings, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioventus LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Igea S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ossatec AS (Norway)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biotronik SE & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DJO Global, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EMS Physio Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Orthocell Ltd. (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Altis Biologics (South Africa)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ISTO Biologics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Regenlab SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Exactech, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Collagen Matrix, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ATEC, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments